Skip to main content

Avantor, Inc.

AVTR
Exchange
NYSE
Industry
Laboratory Analytical Instruments
SEC CIK
0001722482

No open-market purchases or sales by Avantor, Inc. insiders were filed in the last 90 days; 460 institutions reported holding it in 13F filings for Q2 2026, worth $6.92B in total; superinvestors Greenhaven Associates and Southeastern Asset Management (Longleaf) hold it.

Open-market trades, last 90 days

Open-market purchases (P) and sales (S) by Avantor, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.

Open-market buys
0 filings
Open-market sells
0 filings
Insiders trading
0
Net value
$0
Purchases minus sales

Insider roster

Directors, officers and 10% owners who have filed a Form 4 for Avantor, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.

Insider roster for Avantor, Inc.
NameTitleLast reported holdingLast filingFilings, past year
Garner Todd WEVP and CFO49,688Sep 23, 20261
Ligner EmmanuelPresident and CEO737,334Aug 20, 20263
Hankamer BrittanyEVP, Chief HR Officer248,864Aug 18, 20263
Eck Steven WSVP & Chief Accounting Officer129,593Aug 4, 20264
Sokenu ClaudiusEVP, Chief Legal & Compliance251,228Jul 27, 20263
Walker CoreyPresident, VWR Dist. & Servs.384,535Jun 22, 20262
Mehra Sanjeev KDirector33,376May 11, 20263
Summe Gregory LDirector83,381May 11, 20263
Lucier Gregory TDirector60,000IndirectMay 11, 20263
Massaro Joseph RDirector77,408May 11, 20261
Severino MichaelDirector85,821May 11, 20261
Murthy MalaDirector69,479May 11, 20261
Makin LouiseDirector47,140May 11, 20261
Dingemans SimonDirector31,495May 11, 20263
Brellier LudovicEVP, Bioscience & Medtech146,566May 5, 20261
Jones R. BrentEVP, Chief Financial Officer419,782Feb 25, 20262
Gourdier BenoitEVP, Bioscience & Medtech362,859Feb 25, 20263
Blenn MaryEVP, Chief Operating Officer253,384Feb 23, 20262
Couturier ChristopheEVP, AMEA211,271Aug 12, 20250
Stubblefield MichaelPresident & CEO545,500IndirectMay 21, 20250
Peacock Jonathan MDirector219,815May 12, 20250
Andres JuanDirector65,480May 12, 20250
Kang LanDirector52,315May 12, 20250
Carethers JohnDirector45,858May 12, 20250
Bramwell JamesEVP Sales, Customer Excellence86,605Feb 28, 20250
Sahin KittyEVP, Strategy&Corp Development42,274Jul 22, 20240
Stone Randy LeeEVP, Laboratory Solutions68,105Apr 18, 20240
Lewis SheriEVP, Global Ops & Supply Chain70,692Jan 3, 20240
Vanderhaegen FredericEVP, Americas and Europe160,735Aug 28, 20230
Szlosek Thomas AEVP & CFO77,489May 19, 20230
Brophy GerardEVP, Biopharma Production89,032May 19, 20230
Miller JustinEVP & General Counsel93,336May 19, 20230
Shaw ChristiDirector36,271May 15, 20230
Henson MeghanEVP, Chief HR Officer40,184Feb 27, 20230
Wondrasch MichaelEVP & CIO96,072Feb 22, 20230
Holt Matthew S.Director7,908May 16, 20220
Gupta RajivDirector780,562Apr 5, 20220
Murray Mark ChristopherEVP, Biomaterials & AT18,680Jan 18, 20220
Natauri JoDirector557,656IndirectAug 13, 20210

Insider trades

Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Dec 9, 2025 (view filing)Dec 54 daysMehra Sanjeev KDirectorPPurchase+350.0K$11.09+$3.88MNew position350.0K after
Feb 12, 2026 (view filing)Feb 12Same daySumme Gregory LDirectorPPurchase+100.0K$9.40+$940.0K+33.3%400.0K after
Feb 23, 2026 (view filing)Feb 194 daysLucier Gregory TDirectorPPurchase+50.0K$9.16+$458.0KNew position50.0K after
Mar 11, 2026 (view filing)Mar 101 dayMehra Sanjeev KDirectorPPurchase+125.0K$8.01+$1.00M+35.7%475.0K after
May 5, 2026 (view filing)May 14 daysDingemans SimonDirectorPPurchase+25.0K$8.14+$203.5KNew position25.0K after
May 11, 2026 (view filing)May 83 daysLucier Gregory TDirectorPPurchase+10.0K$8.32+$83.2K+20.0%60.0K after